Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis
Vincent Habiyambere(World Health Organization), T. NeSmith(CDC Foundation), Daniel Low‐Beer(World Health Organization), John Stover(Avenir Health), Lara Vojnov(World Health Organization), Joel N. Kuritsky(Texas A&M University – Corpus Christi), Boniface Dongmo Nguimfack(World Health Organization), Sally Hargreaves(St George's, University of London), M. Pérez González, Dianna Edgil(United States Agency for International Development), L. Hasek(Clinton Health Access Initiative), Nathan Ford(World Health Organization), Jason Williams(CDC Foundation), Paolo Maggiore(Clinton Health Access Initiative)
Cited by 36
Related Papers
Increase in primary liver cancer in the UK, 1979–94
|The Lancet|1997|506
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Requirements for global elimination of hepatitis B: a modelling study
|The Lancet Infectious Diseases|2016|384